PubmedID,Title,Publication Date,Non-academic Author(s),Company Affiliation(s),Corresponding Author Email
40640953,Roles of JAK-STAT signaling and granulocyte-macrophage colony-stimulating factor in the development of osteitis and bone microstructure changes in rheumatoid arthritis.,2025-Jul-10,,"Department of Clinical Immunology, Osaka Metropolitan University Graduate School of Medicine, 1-4-3 Asahimachi, Abeno-ku, Osaka, 545-8585, Japan.; Department of Orthopeadic Surgery, Kyoto University, 54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.; Department of Advanced Medicine for Rheumatic Diseases, Kyoto University, Graduate School of Medicine, 54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto, 606- 8507, Japan.; Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, 54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.; Center for Genomic Medicine, Graduate School of Medicine, Kyoto University, 54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.; Department of Clinical Immunology, Osaka Metropolitan University Graduate School of Medicine, 1-4-3 Asahimachi, Abeno-ku, Osaka, 545-8585, Japan. motomu.hashimoto@omu.ac.jp.; Department of Informatics, Graduate School of Informatics, Kyoto University, 54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.; Division of Clinical Immunology and Cancer Immunotherapy, Center for Cancer Immunotherapy and Immunobiology, Graduate School of Medicine, Kyoto University, Bristol Myers Squibb Building, Konoe cho-Yoshida, Sakyo-ku, Kyoto, 606-8501, Japan.",motomu.hashimoto@omu.ac.jp
40640807,Neutrophil membrane-coated circular RNA nanoparticles for targeted immunotherapy in HER2-positive breast cancer brain metastasis.,2025-Jul-10,,"State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Biotechnology Center, School of Pharmacy, Air Force Medical University, Xi'an, 710032, People's Republic of China.",fandong1101@126.com
40640569,Author Correction: Spatial immune scoring system predicts hepatocellular carcinoma recurrence.,2025-Jul-10,Joe Yeong,"Institute of Molecular and Cell Biology (IMCB), Agency for Science Technology and Research (A*STAR), Singapore, Singapore. yeongps@imcb.a-star.edu.sg.; Genome Analysis Laboratory of the Ministry of Agriculture and Rural Affairs, Agricultural Genomics Institute at Shenzhen, Chinese Academy of Agricultural Sciences, Shenzhen, China.; Singapore Immunology Network (SIgN), Agency for Science Technology and Research (A*STAR), Singapore, Singapore. yeongps@imcb.a-star.edu.sg.; Institute of Molecular and Cell Biology (IMCB), Agency for Science Technology and Research (A*STAR), Singapore, Singapore.",yeongps@imcb.a-star.edu.sg
40640525,Targeting mTORC2 in lung squamous cell carcinoma improves anti-tumor immunity through the PSGL-1-VISTA axis.,2025-Jul-10,,"Tennessee Valley Healthcare System, Department of Veterans Affairs, Nashville, TN, USA. jin.chen@vumc.org.; Department of Medicine, Division of Rheumatology, Vanderbilt University Medical Center, Nashville, TN, USA.; Department of Medicine, Division of Rheumatology, Vanderbilt University Medical Center, Nashville, TN, USA. jin.chen@vumc.org.; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA. jin.chen@vumc.org.; Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA. jin.chen@vumc.org.; Department of Cell and Developmental Biology, Vanderbilt University, Nashville, TN, USA. jin.chen@vumc.org.; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.",jin.chen@vumc.org
40640499,"Iron-silver-modified quantum dots act as efficient catalysts in anti-cancer multitherapy through controlled, ultrasound-induced oxidation.",2025-Jul-10,,"CAS Center for Excellence in Nanoscience, Laboratory for Biological Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology (NCNST), Beijing, China.; Key Laboratory of Medical Molecule Science and Pharmaceutics Engineering, Ministry of Industry and Information Technology, School of Chemistry and Chemical Engineering, Institute of Medical-Industrial Integration, Beijing Key Laboratory of Structurally Controllable Advanced Functional Materials and Green Applications, School of Materials Science and Engineering, Beijing Institute of Technology, Beijing, China.; CAS Center for Excellence in Nanoscience, Laboratory for Biological Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology (NCNST), Beijing, China. qiaozy@nanoctr.cn.; Key Laboratory of Medical Molecule Science and Pharmaceutics Engineering, Ministry of Industry and Information Technology, School of Chemistry and Chemical Engineering, Institute of Medical-Industrial Integration, Beijing Key Laboratory of Structurally Controllable Advanced Functional Materials and Green Applications, School of Materials Science and Engineering, Beijing Institute of Technology, Beijing, China. zhangjt@bit.edu.cn.",sergio.brovelli@unimib.it
40640471,Therapeutic targeting of mismatch repair-deficient cancers.,2025-Jul-10,,"Division of Solid Tumour Oncology, Department of Medicine, Memorial Sloan Kettering, New York, NY, USA.; Division of Solid Tumour Oncology, Department of Medicine, Memorial Sloan Kettering, New York, NY, USA. diazl5@mskcc.org.",diazl5@mskcc.org
40640452,Oral mucositis in patients undergoing hematopoietic stem cell transplantation with prophylactic photobiomodulation: A retrospective cohort study.,2025-Jul-11,,"Department of Dentistry, Federal University of Rio Grande Do Norte, Senador Salgado Filho Av., Lagoa Nova, 59056-000 , Natal, Rio Grande Do Norte, 1787, Brazil.; Department of Dentistry, Federal University of Rio Grande Do Norte, Senador Salgado Filho Av., Lagoa Nova, 59056-000 , Natal, Rio Grande Do Norte, 1787, Brazil. ericka_janine@yahoo.com.br.",ericka_janine@yahoo.com.br
40640393,A bispecific antibody-drug conjugate targeting EGFR and HER3 in metastatic esophageal squamous cell carcinoma: a phase 1b trial.,2025-Jul-10,Yi Zhu; Hai Zhu; Sa Xiao,"Department of Gastrointestinal Oncology, State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital and Institute, Beijing, China. goodjf@163.com.; Department of Early Drug Development Centre, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital and Institute, Beijing, China.; Baili-Bio (Chengdu) Pharmaceutical Co. Ltd., Chengdu, China.; Department of Gastrointestinal Oncology, State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital and Institute, Beijing, China. shenlin@bjmu.edu.cn.; Department of Abdominal Radiotherapy, Zhejiang Cancer Hospital, Zhejiang, China.; Department of Gastrointestinal Oncology, State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital and Institute, Beijing, China.; Department of Early Drug Development Centre, State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital and Institute, Beijing, China.; Sichuan Biokin Pharmaceutical Co. Ltd., Chengdu, China.",goodjf@163.com
40640119,DKN-01 and tislelizumab as second-line therapy in DKK1-high gastroesophageal adenocarcinoma: DisTinGuish trial part B.,2025-Jul-10,Mohamad Sonbol; Michael H Kagey; Melissa Stilian; Calvin Jia; Cynthia A Sirard,"Mayo Clinic Hospital, Phoenix, AZ, USA.; MD Anderson Cancer Center, Houston, TX, USA.; Rhode Island Hospital, Brown University Medical Center, Providence, RI, USA.; Leap Therapeutics, Cambridge, MA, USA.; Department of Medicine, Division of Hematology-Oncology, Massachusetts General Hospital, Boston, MA, USA. sklempner@mgb.org.; Advent Health Cancer Institute, Orlando, FL, USA.; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA.; Duke University Medical Center, Durham, NC, USA.",imdoctor@snu.ac.kr
40640091,[Analysis of Efficacy and Safety of Neoadjuvant Immunochemotherapy in Patientswith Stage IB-IIIB Non-small Cell Lung Cancer].,2025-Jun-20,,"Department of Thoracic Surgery, China Thoracic Oncology Institute, Peking University People's Hospital, Research Unit of Intelligence Diagnosis and Treatment in Early Non-small Cell Lung Cancer, Chinese Academy of Medical Sciences, Beijing 100044, China.",
40640089,Diagnosis and treatment of colorectal liver metastases: Chinese expert consensus-based multidisciplinary team (2024 edition).,2025-Jul-10,,"Department of Imaging Diagnosis, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.",
40640073,GDF15: from biomarker to target in cancer cachexia.,2025-Jul-09,,"Department of Clinical Chemistry, University Medical Center Göttingen (UMG), Göttingen, Germany; German Centre for Cardiovascular Research (DZHK), Partner Site Lower Saxony, Göttingen, Germany. Electronic address: andreas.fischer@med.uni-goettingen.de.; Department of Cardiology and Pneumology, University of Göttingen Medical Center (UMG), Göttingen, Germany; German Centre for Cardiovascular Research (DZHK), Partner Site Lower Saxony, Göttingen, Germany.",andreas.fischer@med.uni-goettingen.de
40639983,Oncolytic adenovirus serotype 35 mediated tumor growth suppression via efficient activation of antitumor immunity.,2025-Jul-10,,"Immunology Frontier Research Center, The University of Osaka, Osaka, Japan.; Laboratory of Functional Organoid for Drug Discovery, Center for Drug Discovery Resources Research, National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan.; Global Center for Medical Engineering and Informatics, The University of Osaka, Osaka, Japan.; Laboratory of Biochemistry and Molecular Biology, Graduate School of Pharmaceutical Sciences, The University of Osaka, Osaka, Japan.; Laboratory of Biochemistry and Molecular Biology, School of Pharmaceutical Sciences, The University of Osaka, Osaka, Japan.; Laboratory of Biochemistry and Molecular Biology, Graduate School of Pharmaceutical Sciences, The University of Osaka, Osaka, Japan mizuguch@phs.osaka-u.ac.jp sakurai@phs.osaka-u.ac.jp.; Center for Infectious Disease Education and Research (CiDER), The University of Osaka, Osaka, Japan.; Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives (OTRI), The University of Osaka, Osaka, Japan.",mizuguch@phs.osaka-u.ac.jp
40639936,Endoplasmic Reticulum-Targeting Iridium(III) Complexes Induce Pyroptosis and Enhance Immunogenic Cell Death in MDA-MB-231 Cells.,2025-Jul-10,,"The First Dongguan Affiliated Hospital, School of Pharmacy, Guangdong Medical University, Dongguan 523808, P. R. China.",
40639849,Malevolent alliance of MYBL2hi cancer stem cell and SPP1+ macrophage confers resistance to neoadjuvant immunotherapy in bladder cancer.,2025-Jul-10,,"Key Laboratory of Vascular Aging, Ministry of Education, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.",cynthia@126.com
40639578,Unraveling the role of mucins and gut microbiota in gastrointestinal cancers chemoresistance.,2025-Jul-08,,"Department of Biochemistry and Molecular Biology, Augusta University, Augusta, GA, USA.; Cancer Research Program, BRIC-Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, Kerala, India.; Cancer Research Program, BRIC-Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, Kerala, India; Regional Centre for Biotechnology, Faridabad 121001, Haryana, India.; Cancer Research Program, BRIC-Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, Kerala, India; Regional Centre for Biotechnology, Faridabad 121001, Haryana, India. Electronic address: rameshp@rgcb.res.in.",rameshp@rgcb.res.in
40639449,Stimuli-sensitive hyaluronic acid hydrogels for localized and controlled release of antibodies.,2025-Jul-08,,"School of Pharmacy, University of Camerino, ChIP Chemistry Interdisciplinary Project Research Centre, Via Madonna delle Carceri, 62032 Camerino, MC, Italy.; School of Pharmacy, University of Camerino, ChIP Chemistry Interdisciplinary Project Research Centre, Via Madonna delle Carceri, 62032 Camerino, MC, Italy. Electronic address: cristina.casadidio@unicam.it.; Department of Pharmacy, ""G. D'Annunzio"" Chieti e Pescara University, Via dei Vestini 1, 66100 Chieti, CH, Italy.",cristina.casadidio@unicam.it
40639377,Exercise-induced microbiota metabolite enhances CD8 T cell antitumor immunity promoting immunotherapy efficacy.,2025-Jul-04,,"Genetics and Microbiome Core, Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.; Genetics and Microbiome Core, Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA; Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.; Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Cancer Immunology and Immunotherapy Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA. Electronic address: marlies@pitt.edu.; Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Department of Infectious Diseases and Microbiology, University of Pittsburgh School of Public Health, Pittsburgh, PA, USA.; Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Center for Systems Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.; Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Tsinghua Medicine, School of Medicine, Tsinghua University, Beijing, China.; Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Graduate Program of Microbiology and Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.; Department of Medicine and UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA; Cancer Immunology and Immunotherapy Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.; Department of Nutritional Sciences, University of Vienna, Vienna, Austria; Research Platform Active Ageing, University of Vienna, Vienna, Austria.; Division of Biology, Kansas State University, Manhattan, KS, USA.; Department of Medicine and UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.; Genetics and Microbiome Core, Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA; Basic Science Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.; Department of Nutritional Sciences, University of Wisconsin-Madison, Madison, WI, USA.; Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.; Department of Internal Medicine, Division of Infectious Diseases, University of California, Davis, Davis, CA, USA.; Department of Nutritional Sciences, University of Vienna, Vienna, Austria; Vienna Doctoral School of Pharmaceutical, Nutritional and Sport Sciences (PhaNuSpo), University of Vienna, Vienna, Austria.; Department of Nutritional Sciences, University of Wisconsin-Madison, Madison, WI, USA; Department of Surgery, University of Wisconsin-Madison, Madison, WI, USA.; Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Department of Medicine and UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA; Cancer Immunology and Immunotherapy Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.; Center for Systems Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Joint CMU-Pitt PhD Program in Computational Biology, Carnegie Mellon-University of Pittsburgh, Pittsburgh, PA, USA.; Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Cancer Immunology and Immunotherapy Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA; Institute of Infection, Inflammation, and Immunity, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA, USA.; Department of Cardiovascular & Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA; Center for Microbiome & Human Health, Cleveland Clinic, Cleveland, OH, USA.; Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Health Sciences Mass Spectrometry Core, University of Pittsburgh, Pittsburgh, PA, USA.",marlies@pitt.edu
40639087,Prognostic significance of BATF family genes and correlation with immune infiltration in colorectal cancer.,2025-Jul-05,Hong Yang,"Medical Quality Management Office, Chenggu County Hospital, Hanzhong, China. Electronic address: yanghong7301@163.com.",zhuhongshengcgxyy@126.com
40639020,Approaches to overcome the current treatment plateau in immunotherapy.,2025-Jul-06,Renzo Canetta; Wei Zheng; Young Kim; Ramy Ibrahim; Michael Lahn,"Chief Scientific Officer Parker Institute, 1 Letterman Drive, Suite D3500, San Francisco, CA 94129, USA.; 7 Wallace Way, Chappaqua, NY 10514, USA.; iOnctura SA, Avenue Secheron 15, Geneva 1202, Switzerland.; 7 Sportsman Hill Road, Madison, CT 06443, USA.; Georgiamune Inc., 942 Clopper Rd., Gaithersburg, MD 20878, USA.; Moderna Inc., 325 Binney St., Cambridge, MA 02139, USA.; Earle A. Chiles Research Institute at the Robert W. Franz Cancer Center, Providence Cancer Institute, 4805 NE Glisan St. Suite 2N35, Portland, OR 97213, USA.",maio@unisi.it
40638939,Investigational new drugs to treat brain metastasis from non-small cell lung cancer.,2025-Jul-10,Pasquale Vitale; Ilaria di Giovanni; Raffaele Addeo,"Unita Operativa Complessa Oncologia Ospedale, ""San Giovanni Di Dio"". Frattamaggiore ASLNA2NORD, Frattamaggiore, NA, Italy().",
40638927,Systemic anti-cancer treatment for Māori with stage III and IV non-small cell lung cancer in Aotearoa New Zealand.,2025-Jul-11,,"Medical Oncologist, Auckland City Hospital, Aotearoa New Zealand; Professor of Pharmacology, Faculty of Medical and Health Sciences, The University of Auckland, Aotearoa New Zealand.",
40638868,Early-Onset Colorectal Cancer: From Genetic Discovery to Clinical Innovation.,2025-Jun,,"University of Utah School of Medicine, Salt Lake City, UT.; Center for Cancer Prevention and Control, CECAN, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.; Department of Hematology and Oncology, School of Medicine, Pontificia Universidad Católica de Chile, Red de Salud UC Christus, Cancer Institute, Santiago, Chile.",
40638673,Contributing to a value-based health care framework for lung cancer patients in Switzerland - A methodological approach to merge routinely collected hospital data.,2025,Dominik Glinz; Jessica Thürmer; Flurina Pletscher,"Roche Pharma (Schweiz) AG, Basel, Switzerland.; Quality Management and Value-based Health Care, University Hospital Basel, Basel, Switzerland.; Institute of Pharmaceutical Medicine (ECPM), University of Basel, Basel, Switzerland.",
40638667,In silico identification of promising PD-L1 inhibitors from selected indian medicinal plants for treatment of triple negative breast cancer.,2025,Sk Faisal Ahmed; Md Shohel Hossain; Musab Shahariar; Shormila Akter Sumya; Nahid Sultan Rizu; Lamia Hasan Joarder Barsha,"Dawn of Bioinformatics Limited, Dhaka, Bangladesh.; Department of Pharmacy, Islamic University, Kushtia, Bangladesh.; Department of Pharmacy, Gono Bishwabidyalay, Savar, Dhaka, Bangladesh.; Department of Pharmacy, Primeasia University, Dhaka, Bangladesh.",
40638251,Distinct roles of HMOX1 on tumor epithelium and macrophage for regulation of immune microenvironment in ovarian cancer.,2025-Jul-09,,"Hubei Provincial Key Laboratory for Chinese Medicine Resources and Chinese Medicine Chemistry, School of Pharmacy, Hubei University of Chinese Medicine, Wuhan, China.",
40638246,Combinatorial therapy regimens targeting preclinical models of melanoma resistant to immune checkpoint blockade.,2025-Jul-10,,"Department of Dermatology, University of California San Francisco, San Francisco, United States of America.; California Pacific Medical Center (CPMC) Research Institute, San Francisco, United States of America.",
40638104,Adjuvant Chemoradiation and Immunotherapy for Extrahepatic Cholangiocarcinoma and Gallbladder Cancer: A Randomized Clinical Trial.,2025-Jul-10,,"Key Laboratory of Imaging Diagnosis and Minimally Invasive Intervention Research, Institute of Imaging Diagnosis and Minimally Invasive Intervention Research, The Fifth Affiliated Hospital of Wenzhou Medical University, Affiliated Lishui Hospital of Zhejiang University, Lishui, China.",
40638103,A Novel Adjuvant Chemoradiotherapy/Immunotherapy for Resected Biliary Cancer.,2025-Jul-10,,"Department of Surgery, Division of Surgical Oncology, Moores Cancer Center, UC San Diego, La Jolla, California.",
40637678,Unveiling non-small cell lung cancer treatment effect heterogeneity: a comparative analysis of statistical methods.,2025-Jul-10,,"Department of Psychiatry, Columbia University Irving Medical Center and New York State Psychiatric Institute, New York, NY, USA.; Department of Biostatistics, Columbia University Mailman School of Public Health, New York, NY, USA.; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.",
40637440,HPMA nanomedicine: targeting cancer with precision.,2025-Jul-10,,"Nanopolymeric Drug Delivery Lab, Department of Pharmacy, School of Chemical Sciences and Pharmacy, Central University of Rajasthan, NH-8 Ajmer Jaipur Expressway, Bandarsindri, Ajmer, Rajasthan 305817, India. umeshgupta175@gmail.com.",umeshgupta175@gmail.com
40637334,Advancements in Cutaneous T-Cell Lymphoma Treatment: Unveiling Novel Therapeutic Avenues and Clinical Implications.,2025-Jul-10,,"Department of Medicine, Samaritan Medical Centre, Watertown, NY.",
40637269,Bacterial Foreignization Nanosystem Elicits Multi-Phenotypic T Cells for Antitumor Immunity.,2025-Jul-10,,"State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China.; Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, 3052, Australia.",
40637162,"Chemoimmunotherapy outcomes and prognostic factors in patients with advanced, low PD-L1-expressing non-small cell lung cancer.",2025-Jul-10,Tomohiro Oba; Tomoya Fukui; Makoto Hibino; Asuka Okada,"Saitama Red Cross Hospital, Japan.; Saiseikai Suita Hospital, Japan.; Shonan Fujisawa Tokushukai Hospital, Fujisawa, Japan.; Kansai Medical University, Japan.; St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.; Nagasaki University Graduate School of Biomedical Sciences, Japan.; Shonan Kamakura General Hospital, Kamakura, Kanagawa, Japan.",
40637137,Targeting Cystine Metabolism in the Lung Cancer Environment Enhances the Efficacy of Immune Checkpoint Inhibition.,2025-Jul-10,Yun Xu; Jiaji Wu; Shumin Xu; Mo Shen; Chenyang Wang; Zhiyong Xu; Yueli Shi; Nana Liu; Yunke Yang; Jiangnan Zhao; Ying Yang; Mengshu Li; Kai Wang,"Zhejiang Key Laboratory of Precision Diagnosis and Treatment for Lung Cancer, Yiwu, 322000, China.",
40637077,Association Between Area-Level Socioeconomic Disadvantage and Immunotherapy in Patients With Non-Small Cell Lung Cancer.,2025-Jul,,"Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.",
40636645,Elevated Adrenocorticotropic Hormone After Adrenalectomy or Adrenal Ablation and Immune Checkpoint Inhibitors: Adrenal Insufficiency Is Not Always the Culprit.,2025-Jun,,"Internal Medicine, University of California Los Angeles, Los Angeles, USA.; Hematology-Oncology, University of California Los Angeles, Los Angeles, USA.; Endocrinology, University of California Los Angeles, Los Angeles, USA.",
40636453,"The Multifaceted Role of the IL-2 Cytokine Family in Melanoma: Mechanisms, Therapeutic Implications, and Immune Modulation.",2025,,"Faculty of Medicine, Ondokuz Mayis University, Samsun, Türkiye.; School of Pharmacy, Shahid Beheshti University of Medical Science, Tehran, Iran.",
40636413,Utilizing Immuno-Oncology registry data for enhanced non-small cell lung cancer treatment predictions.,2025-Aug,Subha Madhavan,"John Theurer Cancer Center, Hackensack Meridian Health, Hackensack, NJ, 07061, United States.; Pfizer Research and Development, New York, NY, 11206, United States.",
40636312,An Optimized Method for Single Cell Cloning of Human CAR-T Cells Based on FBS-Coated Plates.,2025-Apr,,"Poultry Viral Vaccines Research and Production Department, Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization, Karaj, Iran.",
40636277,"Cuproptosis: A Review on Mechanisms, Role in Solid and Hematological Tumors, and Association with Viral Infections.",2025,,"Department of Biomedical, Dental, Morphological and Functional Imaging Sciences, University of Messina, Messina, Italy.; Division of Anatomic Pathology and Histology, Catholic University of Sacred Heart, Fondazione Policlinico Universitario ""A. Gemelli"" IRCCS, Rome, Italy.; Department of Human Pathology of Adults and Developmental Age ""Gaetano Barresi,"" Division of Pathology, University of Messina, Messina, Italy.",
40636106,Tracking cellular therapies to optimize homing against liver metastases.,2025,,"Comprehensive Cancer Center, University of California, Davis, Sacramento, CA, United States.; University of California Davis Health, Division of Surgical Oncology, Department of Surgery, Sacramento, CA, United States.",
40635637,Innate and Adaptive Immune Responses to Clinical Hyaluronic Acid Fillers.,2025-Jul,Christopher K Hee,"Department of Biomedical Engineering, Translational Tissue Engineering Center, Wilmer Eye Institute, Johns Hopkins University, Baltimore, Maryland, USA.; Bloomberg~Kimmel Institute for Cancer Immunotherapy, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Allergan Aesthetics, An AbbVie Company, Irvine, California, USA.",
40635600,Therapeutic Indications of Pembrolizumab in Eight Common Cancers: Current Evidence and Future Directions.,2025-Jul,,"Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.",
40634636,Beyond T-cell subsets: stemness and adaptation redefining immunity and immunotherapy.,2025-Jul-10,,"Immunobiology & Transplant Science Center, Department of Surgery, Houston Methodist Research Institute, Houston Methodist Hospital, Houston, TX, USA. wchen@houstonmethodist.org.; Department of Surgery, Weill Cornell Medicine, Cornell University, New York, NY, USA.; Immunobiology & Transplant Science Center, Department of Surgery, Houston Methodist Research Institute, Houston Methodist Hospital, Houston, TX, USA.; Department of Surgery, Weill Cornell Medicine, Cornell University, New York, NY, USA. wchen@houstonmethodist.org.",wchen@houstonmethodist.org
40634511,Targeting proteostasis in multiple myeloma through inhibition of LTK.,2025-Jul-09,,"Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czechia.",t.k.vatsveen@medisin.uio.no
40633935,Therapeutic potential of targeting LAG-3 in cancer.,2025-Jul-08,Ivan Diaz-Padilla,"Harvard Medical School, Boston, Massachusetts, USA.; Department of Medicine, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA davard@upmc.edu.; Oncology Global Clinical Development, GSK, Baar, Switzerland.",davard@upmc.edu
40633934,Gene-expression signature predicts autoimmune toxicity in metastatic melanoma.,2025-Jul-08,Domenico Mallardo; Michael Bailey; Andrew White; Ester Simeone; Lucia Festino; Vito Vanella; Claudia Trojaniello; Maria Grazia Vitale; Margaret Ottaviano; Mariaelena Capone; Caterina Costa; Maria Ingenito; Francesca Sparano; Bianca Arianna Facchini; Alessandra Cesano; Sarah Warren; Paolo A Ascierto,"Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy paolo.ascierto@gmail.com.; Salute Mentale e Fisica e Medicina Preventiva, University of Campania Luigi Vanvitelli, Napoli, Italy.; Research and Development, NanoString Technologies Inc, Seattle, Washington, USA.; Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy.; ESSA Pharma, South San Francisco, California, USA.",paolo.ascierto@gmail.com
40633690,Neoadjuvant Intralesional Targeted Immunocytokines (Daromun) in Stage III Melanoma.,2025-Jul-07,G Elia,"Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.; Gustave Roussy and Paris-Saclay University, Villejuif-Paris, France.; Philochem AG, Otelfingen, Switzerland.",ahauschild@dermatology.uni-kiel.de
40633439,Tumor neoantigens as key drivers of significant anti - tumor immunity in triple - negative breast cancer mouse models.,2025-Jul-08,,"Department of Bio and Brain Engineering, KAIST, Daejeon, Republic of Korea; Penta Medix Co., Ltd., Seongnam, Republic of Korea. Electronic address: jungkyoon@kaist.ac.kr.; Department of Bio and Brain Engineering, KAIST, Daejeon, Republic of Korea; Penta Medix Co., Ltd., Seongnam, Republic of Korea.",syjon@kaist.ac.kr
40633299,Development and validation of a machine learning-based clinical prediction model for monitoring liver injury in patients with pan-cancer receiving immunotherapy.,2025-Jul-05,,"Department of Pharmacy, Zhongshan Hospital, Fudan University, Shanghai, China.",zhang.ningping@zs-hospital.sh.cn
40632978,Consistency and Heterogeneity of Microsatellite Instability (MSI) Status in Paired Biopsy and Surgical Specimens of Colorectal Cancer: A Necessity for MSI Reassessment After Treatment?,2025-Jul,Linghua Yan; Baoye Wei; Fei Liu,"Shanghai Tongshu Biotech Co Ltd, Shanghai, China.",
40632948,"Melanoma 3.0T-Tech Innovations, New Targeted Therapies, and T-Cell Breakthroughs.",2025-Jun,,"Massachusetts General Hospital, Harvard Medical School, Boston, MA.; Sarah Cannon Research Institute, Nashville, TN.",
